Literature DB >> 28251541

Profile of Pediatric Idiopathic Inflammatory Myopathies from a Tertiary Care Center of Eastern India.

Sumantra Sarkar1, Tanushree Mondal2, Arpan Saha3,4, Rakesh Mondal5, Supratim Datta1.   

Abstract

OBJECTIVES: To report data on Idiopathic inflammatory myopathies (IIM) from eastern India.
METHODS: All IIM patients diagnosed over the last 5 y (2011-2016) were included through a retrospective review of records from the hospital and specialty clinic at Institute of Postgraduate Medical Education & Research (I.P.G.M.E.&R.), Kolkata.
RESULTS: Out of the 11 IIM patients, 9 had Juvenile dermatomyositis (JDM) and 2 had overlap myositis (OM) [with systemic lupus erythematosus (SLE) and scleroderma]. The overall sex ratio was M: F = 1: 2.6. The mean age at diagnosis was 6.94 y for JDM and 7 y for OM. The mean interval from onset to diagnosis was 5.2 mo. All patients had heliotrope rash and proximal myopathy (n = 11,100%). Other findings included Gottron papule (n = 7; 64%), arthritis (n = 6; 54%), malar rash (n = 5; 45%), dysphagia (n = 4; 36%), nasal intonation (n = 3; 27%), subcutaneous nodule (n = 2; 18%), cutaneous sinus (n = 1; 9%), calcinosis universalis (n = 1; 9%), GI bleed (n = 1; 9%). All patients had raised erythrocyte sedimentation rate (ESR), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) while 10 had raised creatine kinase (CK). Three were anti-nuclear-antibody (ANA) positive. Electromyography (EMG) showed proximal myopathy in most cases (n = 9; 82%). All patients received corticosteroid. Intravenous immunoglobulin (IVIG) was given to 2 patients. Two received hydroxychloroquine. Cyclophosphamide and azathioprine were given in one each.
CONCLUSIONS: This study, first reported profile of IIM from eastern India, showed JDM as the commonest form of IIM with a female preponderance. Five children had complete and 2 had partial remission. Two patients of JDM and 1 of OM died. Increased awareness, early referral, prompt diagnosis and treatment might improve the outcome and survival.

Entities:  

Keywords:  Dermatomyositis; Eastern India; Inflammatory; Juvenile; Myopathy; Profile

Mesh:

Substances:

Year:  2017        PMID: 28251541     DOI: 10.1007/s12098-017-2302-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  28 in total

Review 1.  Idiopathic inflammatory myopathies in childhood: current concepts.

Authors:  Adam M Huber
Journal:  Pediatr Clin North Am       Date:  2012-04       Impact factor: 3.278

2.  Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference.

Authors:  Adam M Huber; Edward H Giannini; Suzanne L Bowyer; Susan Kim; Bianca Lang; Carol B Lindsley; Lauren M Pachman; Clarissa Pilkington; Ann M Reed; Robert M Rennebohm; Lisa G Rider; Carol A Wallace; Brian M Feldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

3.  Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.

Authors:  Angelo Ravelli; Lucia Trail; Cristina Ferrari; Nicolino Ruperto; Angela Pistorio; Clarissa Pilkington; Susan Maillard; Sheila K Oliveira; Flavio Sztajnbok; Ruben Cuttica; Matilde Beltramelli; Fabrizia Corona; Maria Martha Katsicas; Ricardo Russo; Virginia Ferriani; Ruben Burgos-Vargas; Silvia Magni-Manzoni; Eunice Solis-Valleoj; Marcia Bandeira; Francesco Zulian; Vicente Baca; Elisabetta Cortis; Fernanda Falcini; Maria Alessio; Maria Giannina Alpigiani; Valeria Gerloni; Claudia Saad-Magalhaes; Rosanna Podda; Clovis A Silva; Loredana Lepore; Enrico Felici; Federica Rossi; Elena Sala; Alberto Martini
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-01-15       Impact factor: 4.794

4.  Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients.

Authors:  Adriana Maluf Elias Sallum; Maria Helena Bittencurt Kiss; Silvana Sachetti; Maria Bernadate Dutra Resende; Kelly Cristina Moutinho; Mary de Souza Carvalho; Clovis Arthur Almeida Silva; Suely Kazue Nagahashi Marie
Journal:  Arq Neuropsiquiatr       Date:  2003-01-15       Impact factor: 1.420

5.  Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?

Authors:  Shiva Prasad; Ramnath Misra; Vikas Agarwal; Able Lawrence; Amita Aggarwal
Journal:  Int J Rheum Dis       Date:  2013-10       Impact factor: 2.454

6.  Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis.

Authors:  Clara Malattia; Maria Beatrice Damasio; Annalisa Madeo; Angela Pistorio; Anna Providenti; Silvia Pederzoli; Stefania Viola; Antonella Buoncompagni; Chiara Mattiuz; Agnese Beltramo; Alessandro Consolaro; Angelo Ravelli; Nicolino Ruperto; Paolo Picco; Gian Michele Magnano; Alberto Martini
Journal:  Ann Rheum Dis       Date:  2013-05-01       Impact factor: 19.103

7.  Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.

Authors:  L M Pachman; J R Hayford; A Chung; C A Daugherty; M A Pallansch; C W Fink; H L Gewanter; R Jerath; B A Lang; J Sinacore; I S Szer; A R Dyer; M C Hochberg
Journal:  J Rheumatol       Date:  1998-06       Impact factor: 4.666

8.  Therapy of calcinosis universalis complicating adult dermatomyositis.

Authors:  Georgina Terroso; Miguel Bernardes; Abelha Aleixo; Pedro Madureira; Romana Vieira; Alexandra Bernardo; Lúcia Costa
Journal:  Acta Reumatol Port       Date:  2013 Jan-Mar       Impact factor: 1.290

9.  Twelve years experience of juvenile dermatomyositis in North India.

Authors:  Surjit Singh; Arun Bansal
Journal:  Rheumatol Int       Date:  2005-09-15       Impact factor: 3.580

Review 10.  Idiopathic Inflammatory Myopathies: Clinical Approach and Management.

Authors:  Asma Malik; Ghazala Hayat; Junaid S Kalia; Miguel A Guzman
Journal:  Front Neurol       Date:  2016-05-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.